Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7,14-methano-2h,6h-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, Dodecahydro-, (7s-(7alpha,7aalpha,14alpha,14abeta))-
2. Alpha Isosparteine
3. Alpha-isosparteine
4. Anhydrous, Sparteine Sulfate
5. Beta Isosparteine
6. Beta-isosparteine
7. D-sparteine
8. Depasan Retard
9. Genisteine Alkaloid
10. L-sparteine
11. Lupinidin
12. Lupinidine
13. Pachycarpine
14. Pachycarpine Sulfate (1:1), Pentahydrate, (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer
15. Sparteine
16. Sparteine Hydrochloride, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer
17. Sparteine Hydrochloride, (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer
18. Sparteine Hydroiodide, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer
19. Sparteine Monohydrochloride, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer
20. Sparteine Monohydroiodide, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer
21. Sparteine Sulfate
22. Sparteine Sulfate (1:1), (7s-(7alpha,7aalpha,14alpha,14aalpha))-isomer
23. Sparteine Sulfate (1:1), (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer
24. Sparteine Sulfate Anhydrous
25. Sparteine, (+)-isomer
26. Sparteine, (-)-isomer
27. Sparteine, (7r-(7alpha,7aalpha,14alpha,14abeta))-isomer
28. Sparteine, (7r-(7alpha,7abeta,14alpha,14abeta))-isomer
29. Sparteine, (7s-(7alpha,7aalpha,14alpha,14aalpha))-isomer
30. Sparteine, (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer
31. Sparteine, (7s-(7alpha,7abeta,14alpha,14abeta))-isomer
32. Sulfate Anhydrous, Sparteine
1. Sparteine Sulfate
2. 299-39-8
3. Tocosimplex
4. (-)-sparteine (sulfate)
5. Actospar
6. Depasan
7. Sparteal
8. Spartepur
9. Spartin
10. Spartocin
11. Spatym
12. Sparm
13. Spal
14. Tocosamine Sulfate
15. Nsc26253
16. Sparteine, (d)
17. 7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric Acid
18. Wln: T C66 K66 A Hn Pntj &wsqq
19. Sparteine, Sulfate (1:1)
20. (-)-sparteine Sulfate
21. 7,6h-dipyrido[1,2-a:1',2'-e][1,2]diazocine, Dodecahydro-, Sulfate
22. Nsc-143087
23. 7,6h-dipyrido[1,2-a:1',2'-e][1,5]diazocine, Dodecahydro-, [7s-(7.alpha.,7a.alpha.,14.alpha.,14a.beta.)]-, Sulfate (1:1)
24. Nsc376144
25. Schembl636202
26. Sulfato--sparteinato (1/1)
27. Chembl1968726
28. Dtxsid50952348
29. (-)-sparteine-sulfate-pentahydrate
30. Nsc-26253
31. Nsc143087
32. Nsc402663
33. Akos003368041
34. Am84911
35. Nsc-376144
36. Nsc-402663
37. Ft-0674636
38. A876348
Molecular Weight | 332.5 g/mol |
---|---|
Molecular Formula | C15H28N2O4S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Exact Mass | 332.17697855 g/mol |
Monoisotopic Mass | 332.17697855 g/mol |
Topological Polar Surface Area | 89.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 344 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 4 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Oxytocics
Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
ABOUT THIS PAGE
A Sparteine Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sparteine Sulfate, including repackagers and relabelers. The FDA regulates Sparteine Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sparteine Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sparteine Sulfate supplier is an individual or a company that provides Sparteine Sulfate active pharmaceutical ingredient (API) or Sparteine Sulfate finished formulations upon request. The Sparteine Sulfate suppliers may include Sparteine Sulfate API manufacturers, exporters, distributors and traders.
Sparteine Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sparteine Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sparteine Sulfate GMP manufacturer or Sparteine Sulfate GMP API supplier for your needs.
A Sparteine Sulfate CoA (Certificate of Analysis) is a formal document that attests to Sparteine Sulfate's compliance with Sparteine Sulfate specifications and serves as a tool for batch-level quality control.
Sparteine Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Sparteine Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sparteine Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sparteine Sulfate EP), Sparteine Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sparteine Sulfate USP).
LOOKING FOR A SUPPLIER?